European Archives - Page 409 of 1145 - European Medical Journal

Christy Seigel

Season finale: Going the extra mile for patients with disabilities

Join Jade as she sits down with Christy Seigel, General Manager, Breast and Women’s Cancers Portfolio, Novartis US Oncology, to discuss the importance of disability inclusion in the pharmaceutical industry.

Cirrhosis Mortality Risk: The Impact of Animal Protein Intake

According to new research, higher animal protein intake is associated with greater mortality risk in patients with liver cirrhosis…

The Effects of Endocrine Disrupting Chemicals on the Outcomes of Pregnancy and Fertility Treatments Should Not Be Underestimated

Infertility rates are rising. Infertility is generally defined as the failure to establish clinical pregnancy after 12 months of regular…

Systemic Sclerosis Manifesting Post-Radiotherapy: A Case Report

Morphoea causes skin and subcutaneous tissue fibrosis, and can sometimes involve the fascia, muscle, or bone. Sclerosis usually begins as…

EMJ Reproductive Health 9.1 2023

We are excited to announce the latest issue of EMJ Reproductive Health, including a review of the European Society of Human Reproduction…

ESHRE 2023 Abstract Highlights

POLYCYSTIC ovary syndrome (PCOS) is strongly linked to cardiovascular risk factors. However, in females (aged 40–60 years)…

Review of the European Society of Human Reproduction and Embryology (ESHRE) Annual Meeting 2023

The 39th European Society of Human Reproduction and Embryology (ESHRE) Annual Meeting, which took place in Copenhagen, Denmark…

Incidence, Risk Factors, and Aetiologies of Primary Postpartum Haemorrhage After Vaginal Delivery in Kasr Al Ainy University Hospital: A Cross-Sectional Study

Every year, over 300,000 females die due to complications in pregnancy and childbirth, and approximately 15% of all females…

Guidelines on Unexplained Infertility

Romualdi began by stating that putting the guidelines together included gathering evidence of efficacy and evidence of safety, with a…

Debate: Mild Versus Conventional Stimulation in Assisted Reproductive Technology

Geeta Nargund, St George’s Hospital, London, UK, kicked off the debate, suggesting mild stimulation is the future of ART…